CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 54,200 shares, an increase of 30.6% from the November 30th total of 41,500 shares. Currently, 0.9% of the shares of the company are short sold. Based […]
CNS Pharmaceuticals (CNSP) Announces Successful Interim Analysis of Efficacy and Safety Data in Study of Berubicin streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CNS Pharmaceuticals (CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efficacy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 67,000 shares, a decline of 45.2% from the August 31st total of 122,300 shares. Currently, 1.6% of the company’s stock are sold short. […]
CNS Pharmaceuticals (CNSP) Presents Updated Results from On-Going Study of Berubicin streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.